Thursday, December 1, 2022
HomeCANADAModerna To Supply 12 Million Doses Of Omicron-Targeted Covid Shot To Canada

Moderna To Supply 12 Million Doses Of Omicron-Targeted Covid Shot To Canada

Moderna announced that the Government of Canada has exercised its option to purchase an additional 4.5 million doses of an Omicron-containing bivalent vaccine booster candidate from the Company, in addition to moving forward the scheduled delivery of 1.5 million doses of the bivalent vaccine candidate from 2023 to 2022.

Moderna and the Government of Canada have also agreed to convert six million doses of the Company’s COVID-19 vaccine (Spikevax, mRNA-1273) to an Omicron-containing bivalent vaccine. The agreement is subject to regulatory approval of the Omicron-containing bivalent vaccine booster candidate by Health Canada, with doses scheduled for delivery in 2022.

“We thank the Government of Canada for their trust in our mRNA technology and our next-generation bivalent COVID-19 vaccine platform,” said Stéphane Bancel, Moderna’s Chief Executive Officer. “As we have seen throughout this pandemic, the Government of Canada continues to take important steps in preparing for the winter season and protecting its people against Omicron.”

RELATED ARTICLES
0 0 votes
Article Rating
Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments
- Advertisment -
Google search engine

Most Popular

0
Would love your thoughts, please comment.x
()
x